An analysis of serum heparan sulfate concentration and EGFR tyrosine kinase inhibitor treatment in patients with non-small cell lung adenocarcinoma.
M. Nishio
No relevant relationships to disclose
T. Yamanaka
No relevant relationships to disclose
K. Matsumoto
No relevant relationships to disclose
H. Kimura
No relevant relationships to disclose
K. Sakai
No relevant relationships to disclose
A. Sakai
No relevant relationships to disclose
T. Sone
No relevant relationships to disclose
A. Horiike
No relevant relationships to disclose
F. Koizumi
No relevant relationships to disclose
K. Kasahara
No relevant relationships to disclose
T. Ohira
No relevant relationships to disclose
N. Ikeda
No relevant relationships to disclose
N. Saijo
No relevant relationships to disclose
T. Arao
No relevant relationships to disclose
K. Nishio
No relevant relationships to disclose